Literature DB >> 1712679

The nature of the epithelium in acquired cholesteatoma.

R J Lee1, I C Mackenzie, B K Hall, B J Gantz.   

Abstract

Monoclonal antibodies with defined specifications for individual cytokeratins were used to stain the epithelia of the external auditory meatus, the middle ear and cholesteatoma. The observed staining indicated that the epithelium of the external auditory meatus has a pattern of keratin expression typical of epidermis in general and the epithelium of the middle ear resembles simple columnar epithelia. The pattern of staining of cholesteatoma closely resembled that of the skin of the external auditory meatus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712679     DOI: 10.1111/j.1365-2273.1991.tb01970.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

1.  Transcription and microRNA Profiling of Cultured Human Tympanic Membrane Epidermal Keratinocytes.

Authors:  Peder Aabel; Tor Paaske Utheim; Ole Kristoffer Olstad; Helge Rask-Andersen; Rodney James Dilley; Magnus von Unge
Journal:  J Assoc Res Otolaryngol       Date:  2018-04-05

2.  Photodynamic effect of argon and diode laser on cholesteatoma cell cultures after intravital staining with absorption enhancers.

Authors:  B Sedlmaier; A Franke; H Sudhoff; S Jovanovic; A Haisch
Journal:  Lasers Med Sci       Date:  2005-03-17       Impact factor: 3.161

3.  Cholesteatoma growth and proliferation: posttranscriptional regulation by microRNA-21.

Authors:  David R Friedland; Rebecca Eernisse; Christy Erbe; Nidhi Gupta; Joseph A Cioffi
Journal:  Otol Neurotol       Date:  2009-10       Impact factor: 2.311

Review 4.  Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives.

Authors:  Mahmood A Hamed; Seiichi Nakata; Ramadan H Sayed; Hiromi Ueda; Badawy S Badawy; Yoichi Nishimura; Takuro Kojima; Noboru Iwata; Ahmed R Ahmed; Khalid Dahy; Naoki Kondo; Kenji Suzuki
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.